Precision medicine (PM) requires the delivery of individually adapted medical care based on
the genetic characteristics of each patient and his/her tumor. The last decade witnessed the …

Neuroblastoma is a tumor of the peripheral sympathetic nervous system 1 , derived from
multipotent neural crest cells (NCCs). To define core regulatory circuitries (CRCs) controlling …

Circulating tumor DNA (ctDNA) is a new circulating tumor biomarker which might be used as
a prognostic biomarker in a way similar to circulating tumor cells (CTCs). Here, we used the …

Background We previously reported that impaired type I IFN activity, due to inborn errors of
TLR3- and TLR7-dependent type I interferon (IFN) immunity or to autoantibodies against type …

Neuroblastoma is a pediatric cancer of the peripheral nervous system in which structural
chromosome aberrations are emblematic of aggressive tumors. In this study, we performed an in…

Background & Aims The “French Medicine Genomic program 2025” has been designed to
give patients with cancers that are refractory to systemic treatments access to off-label …

Nicotinamide adenine dinucleotide (NAD) is essential for embryonic development. To date,
biallelic loss-of-function variants in 3 genes encoding nonredundant enzymes of the NAD de …

Motivation: ChIP-seq consists of chromatin immunoprecipitation and deep sequencing of the
extracted DNA fragments. It is the technique of choice for accurate characterization of the …

Neurofibromatosis type 1 (NF1) is an autosomal dominant disease with complete
penetrance but highly variable expressivity. In most patients, Next Generation Sequencing (NGS) …

Biallelic variants of the gene encoding for the zinc‐finger protein 142 (ZNF142) have
recently been associated with intellectual disability (ID), speech impairment, seizures, and …